Pharmacological Characterization of FR194921, a New Potent, Selective, and Orally Active Antagonist for Central Adenosine A_1 Receptors
スポンサーリンク
概要
- 論文の詳細を見る
- Japanese Pharmacological Societyの論文
- 2004-09-20
著者
-
MATSUOKA Nobuya
Medicinal Biology Research Laboratories, Astellas Pharmaceutical Inc.
-
MUTOH Seitaro
Medicinal Biology Research Laboratories, Astellas Pharmaceutical Inc.
-
Matsuoka Nobuya
Medicinal Biology Research Laboratories Astellas Pharmaceutical Inc.
-
Matsuoka Nobuya
Medicinal Biology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
IWASHITA Akinori
Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co. Ltd.
-
KURODA Satoru
Medicinal Chemistry Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
AKAHANE Atsushi
Medicinal Chemistry Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
MAEMOTO Takuya
Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
TADA Miho
Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
MIHARA Takuma
Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
UEYAMA Noriko
Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
MATSUOKA Hideaki
Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
HARADA Katsuya
Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
YAMAJI Takayuki
Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
SHIRAKAWA Kiyoharu
Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Iwashita Akinori
Medicinal Biology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Tada Miho
Medicinal Biology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Ueyama Noriko
Medicinal Biology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Kuroda S
Medicinal Chemistry Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Harada Katsuya
Medicinal Biology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Maemoto Takuya
Medicinal Biology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Mihara Takuma
Medicinal Biology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Kuroda Satoru
Medicinal Chemistry Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Mutoh Seitaro
Medicinal Biology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Matsuoka Hideaki
Medicinal Biology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Akahane Atsushi
Medicinal Chemistry Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Yamaji Takayuki
Medicinal Biology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Shirakawa Kiyoharu
Medicinal Biology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
関連論文
- Tacrolimus (FK506) Limits Accumulation of Granulocytes and Platelets and Protects against Brain Damage after Transient Focal Cerebral Ischemia in Rat(Pharmacology)
- An application of a new planar positron imaging system (PPIS) in a small animal : MPTP-induced parkinsonism in mouse
- Implitapide, a Microsomal Triglyceride Transfer Protein Inhibitor, Reduces Progression of Atherosclerosis in Apolipoprotein E Knockout Mice Fed a Western-Type Diet : Involvement of the Inhibition of Postprandial Triglyceride Elevation(Pharmacology)
- Antiemetic Activity of FK1052, a 5-HT_3- and 5-HT_4-Receptor Antagonist, in Suncus murinus and Ferrets
- Design, Synthesis and Biological Evaluation of a Novel Series of Potent, Orally Active Adenosine A_1 Receptor Antagonists with High Blood-Brain Barrier Permeability
- Pharmacological Characterization of FR194921, a New Potent, Selective, and Orally Active Antagonist for Central Adenosine A_1 Receptors
- Antiemetic Activity of FK1052, a 5-HT3- and 5-HT4-Receptor Antagonist, in Suncus murinus and Ferrets
- Pharmacological Characterization of FR194921, a New Potent, Selective, and Orally Active Antagonist for Central Adenosine A1 Receptors